Latest news
Loading news…
ILC Therapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Newhouse, North Lanarkshire, United Kingdom Founded 2012 1-10 employees For Profit
ILC Therapeutics is an early-stage biotechnology company focused on modulating the Innate Immune System.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
6
Patents
11
5 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 4
- Patents granted
- 11
- Trademarks
- 5
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $66K
Company Info
- Founded
- 2012
- Employees
- 1-10
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- News articles
- 16
- HQ
- Newhouse, North Lanarkshire, United Kingdom
- Region
- Europe, Middle East, and Africa (EMEA)
Signals & Scores
- Heat score
- Medium
- Growth score
- Low
- Trend (7d)
- 0
- Trend (30d)
- 0
- Trend (90d)
- -1.2
Key People at ILC Therapeutics
Chief Executive Officer
6
professional contacts at ILC Therapeutics
Contact execs at ILC Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to ILC Therapeutics
Loading news…
FAQs about ILC Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.